Anticoagulant Citrate Phosphate Dextrose (Cpd) Blood-Pack Units In Pl 146 Plastic (Anticoagulant Citrate Phosphate Dextrose (Cpd)) Drug Interactions

Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.

A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Anticoagulant Citrate Phosphate Dextrose (Cpd) Blood-Pack Units In Pl 146 Plastic. Always confirm against the full prescribing information.

100 interactions

Acebutolol

Sodium phosphate, monobasic may increase the hyperkalemic activities of Acebutolol.

Level 2 evidence

Aceclofenac

The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Sodium citrate.

Level 1 evidence

Aceclofenac

The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Aceclofenac.

Level 2 evidence

Acenocoumarol

The risk or severity of bleeding can be increased when Acenocoumarol is combined with Sodium citrate.

Level 2 evidence

Acetazolamide

Acetazolamide may increase the nephrotoxic activities of Sodium phosphate, monobasic.

Level 2 evidence

Acetylsalicylic acid

The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Acetylsalicylic acid.

Level 2 evidence

Acetylsalicylic acid

Acetylsalicylic acid may increase the anticoagulant activities of Sodium citrate.

Level 1 evidence

Aliskiren

The risk or severity of nephrotoxicity can be increased when Aliskiren is combined with Sodium phosphate, monobasic.

Level 1 evidence

Alteplase

The risk or severity of bleeding can be increased when Alteplase is combined with Sodium citrate.

Level 2 evidence

Aluminum hydroxide

Sodium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.

Level 2 evidence

Amifampridine

The risk or severity of seizure can be increased when Sodium phosphate, monobasic is combined with Amifampridine.

Level 2 evidence

Amiloride

Amiloride may increase the nephrotoxic activities of Sodium phosphate, monobasic.

Level 2 evidence

Enter your NPI to unlock 12 major interactions for Anticoagulant Citrate Phosphate Dextrose (Cpd) Blood-Pack Units In Pl 146 Plastic

I don't know my NPI#

More tools for Anticoagulant Citrate Phosphate Dextrose (Cpd) Blood-Pack Units In Pl 146 Plastic

Check coverage & formularyVerify PA requirements for your patient's plan.Prior authorization formsDownload PA forms and appeal templates.Find savings programsCopay cards, patient assistance, and more.

Frequently Asked Questions (FAQ)